Overview of the EPM Solution Chain

In 2011, John Klein founded Cambridge Therapeutics in Alpine, New Jersey, where he currently serves as chairman. Four years later, John Klein expanded his professional endeavors beyond Cambridge Therapeutics by founding Bilogix, LLC, an enterprise performance management (EPM) services provider also based in Alpine, NJ.

The EPM solution chain consists of five key points that can be optimized to address the needs of specific industries and vendors. Strategy and metrics visualization is the first step in the EPM solution chain and involves a number of strategy maps and business activity monitoring processes, along with the scorecards and dashboards often associated with EPM support. Enterprise planning and budgeting, meanwhile, can be described as the strategic integration of budgeting and forecasting applications with tactical enterprise planning efforts.

Financial modeling and analysis is another important part of the EPM solution chain and can be achieved through a range of processes, from cost and profitability modeling to cost and chargeback system. Business reporting processes along the EPM solution chain consist not only of comprehensive management reporting for customers but also options for optimized financial consolidation.

Finally, the EPM solution chain relies on a fully integrated performance management system, which allows for reporting on highly concentrated performance metrics.

Comments

Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services. Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur. This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and r...

Costs Associated with Enterprise Performance Management

An award-winning pharmaceutical executive based in Alpine, New Jersey, John Klein founded Cambridge Therapeutics and Bi-Logix, LLC, in 2011 and 2015, respectively (both located in Alpine, NJ). Bi-Logix, LLC, is an enterprise performance management (EPM) firm that helps companies obtain sustainable measured performance via its proprietary business solutions and methodology, which is copyrighted by John Klein. EPM solutions help businesses improve their IT infrastructure and increase overall corporate efficiency, which, in turn, helps them cut costs and increase revenue. While there are costs associated with EPM implementation, its long-term benefits significantly outweigh the impact of short-term spending. In addition to paying for EPM software licensing and maintenance, businesses might also have to budget costs for database software to help run the EPM. Other costs that might be accrued include the maintenance and upgrading of hardware, as well as fees for third-party inte...

NJ Attorney General Reveals Measures to Combat Opioid Epidemic

The chairman of Cambridge Therapeutics in Teaneck, New Jersey, John Klein has obtained FDA approval for more than 300 generic drugs in the course of his 30-year career. His work at Cambridge Therapeutics has resulted in honors including high ranking on Forbes’ list of the Top 100 CEOs. Complementing that work, John Klein closely follows health and related developments in New Jersey. The state’s attorney general, Gurbir Grewal, recently announced new efforts aimed at battling the state’s opioid epidemic. Grewal has proposed a rule change to make medication-assisted treatment, long recognized as the most effective way to treat opioid addiction, more widely available to the state’s residents through use of telemedicine technology. Allowing physicians to assess and prescribe treatments to patients through two-way, real-time video communication will ensure more people can access medication-assisted treatment and improve their odds of surviving their opioid addiction. In addition, Grewa...

John Klein - Guiding Cambridge Therapeutics in New Jersey

Search This Blog